nimbin has been researched along with Osteogenic Sarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Hazani, TM; Aljarba, NH; Arockiaraj, J; Arokiyaraj, S; Guru, A; Sudhakaran, G; Velayutham, M | 1 |
| Casida, JE; Cohen, E; Quistad, GB | 1 |
2 other study(ies) available for nimbin and Osteogenic Sarcoma
| Article | Year |
|---|---|
Nimbin (N1) and analog N3 from the neem seeds suppress the migration of osteosarcoma MG-63 cells and arrest the cells in a quiescent state mediated via activation of the caspase-modulated apoptotic pathway.
Topics: Animals; Antineoplastic Agents; Apoptosis; Azadirachta; Caspases; Cell Line, Tumor; Cell Proliferation; Osteosarcoma; Rats; Rhodamine 123; Seeds; Zebrafish | 2023 |
Cytotoxicity of nimbolide, epoxyazadiradione and other limonoids from neem insecticide.
Topics: Animals; Cell Line; Cell Survival; Cytotoxins; Diterpenes; Humans; Insecticides; Lactones; Limonins; Male; Mice; Neuroblastoma; Norsteroids; Osteosarcoma; Rabbits; Seeds; Sperm Motility; Spermatozoa; Spodoptera; Structure-Activity Relationship; Triterpenes; Tumor Cells, Cultured | 1996 |